NF-IL6 was originally identified as a DNA binding protein regulating interleukin-1 (IL-1)-stimulated IL-6 expression. Direct cloning of NF-IL6 showed its homology with C/EBP, a hepatocyte-and adipocyte-specific transcription factor. This study showed that the expression of NF-IL6 messenger RNA (mRNA) increased markedly during the differentiation to a macrophage lineage in mouse myeloid leukemia cells Ml, human histiocytic leukemia cells U937, promyelocytic leukemia cells HL-60, and human peripheral monocytes. Particularly in HL-60 cells that undergo granulocyte or macrophage differentiation depending on inducers, NF-116 mRNA was PREVIOUSLY identified a nuclear factor, NFw IL6, responsible for interleukin-6 (IL-6) expression and cloned the gene encoding human NF-IL6.'.* Recently rat (LAP and ILdDBP) and mouse (AGP-EBP) homolog~~-' of NF-IL6 were cloned. Roman et aI6 reported the isolation of a novel cDNA encoding IglEBP-1 that bound specifically to the Ig heavy chain enhancer as well as its promoter regions. Interestingly, NF-IL6 (LAP/IL-6DBP/ AGP-EBP) and IglEBP-1 showed high homology to CIEBP' in their DNA binding domains and leucine zipper regions, showing the existence of a family of C/EBP-related molecules. These members of the ClEBP family recognize the same nucleotide sequence, but exhibit distinct patterns of expression, suggesting their functional difference. C/EBP messenger RNA (mRNA) is found in adipose, liver, and placental tissues and it is suggested that C/EBP may play a vital role in energy Indeed, the promoters of several hepatocyte-and adipocyte-specific genes, including serum albumin," PEPCK," 422laP2 protein, stearoyl acylCoA desaturase-l,'* and the insulin-responsive glucose transp~rter'~ genes, were found to be trans-activated by CIEBP. Ig/EBP-1 mRNA was shown to be expressed ubiquitously but with its highest level in early B cells.' Elevated expression of IglEBP-1 in early B-lineage cells is considered to be responsible in part for the enhancerindependent activity of the V, promoter in B-cell development. In contrast, NF-IL6 (LAPIILdDBPIAGP-EBP) mRNA is expressed at a low level in normal tissues but drastically and rapidly induced in many tissues by lipopo- lysaccharide (LPS) or several inflammatory cytokines including IL-1, tumor necrosis factor (TNF), and IL-6, indicating that NF-IL6 may be involved in the regulation of the genes activated in inflammatory reactions.*
specifically upregulated during macrophage differentiation but not granulocyte differentiation. It was also shown that the functional NF-IL6 protein increased during the differentiation of U937 cells. Furthermore, recombinant NF-116 was found to bind to the regulatory regions of the IL-I, tumor necrosis factor, granulocyte colony-stimulating factor, and lysozyme genes, which are expressed in mature macrophages. These results suggest that NF-IL6 may possibly be involved as an important transcription factor in the process of activation and/or differentiation of macrophages. 0 1992 by The American Society of Hematology.
lysaccharide (LPS) or several inflammatory cytokines including IL-1, tumor necrosis factor (TNF), and IL-6, indicating that NF-IL6 may be involved in the regulation of the genes activated in inflammatory reactions.*
In this study, we show that NF-IL6 is upregulated during macrophage differentiation and responsible for the regulation of the genes expressed in mature macrophages, indicating that NF-IL6 is possibly an important transcription factor for macrophage activation andlor differentiation.
MATERIALS AND METHODS

Cells.
Myeloid leukemia M1 cells were cultured in Eagle's minimal essential medium supplemented with twice the normal concentrations of amino acids and vitamins and 10% fetal calf serum (FCS). Human histiocytic leukemia U937 and human promyelocytic leukemia HL-60 cell lines were cultured in RPMI 1640 supplemented with 10% FCS. M1 cells were treated with recombinant human IL-6 (rhIL-6) at a concentration of 500 UimL and leukemia inhibitory factor (LIF) at a concentration of 2,500 UlmL, respectively. LIF was kindly provided by Dr Nicos A. Nicola (Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia). U937 cells were treated with 10 pg1mL of LPS and 10 ng/mL of phorbol myristate acetate (PMA). HL-60 cells were kindly provided by Dr Etsuko Abe (Showa University, Tokyo, Japan) and were treated with dimethyl sulfoxide (DMSO; final concentration, 1.25%) or PMA (final concentration, 107 nmoliL). Human peripheral monocytes were separated from heparinized blood with Ficoll-Paque (Pharmacia LKB Biotechnology, Uppsala, Sweden) and Sepracell-MN (Sepratech, Oklahoma City, OK) as described previo~sly.'~ The monocyte fraction contained more than 80% esterase+ cells when determined by nonspecific esterase staining. For the LPS treatment, the isolated monocytes were cultured in RPMI 1640 medium supplemented with 10% FCS containing 10 pgimL of LPS for 16 hours.
Cytoplasmic RNA was obtained by a guanidine isothiocyanate-cesium chloride gradient centrifugation m e t h~d . '~ Cytoplasmic poly(A)' RNAs (2 pg per lane) were separated on 1% agarose-formaldehyde gels, transferred to GeneScreen Plus membranes (DuPont, Boston, MA) and hybridized with the '2P-labeled probe in 50% formamide, 1% sodium dodecyl sulfate (SDS), 1 mollL NaC1, and 10% dextran sulfate at 42°C for 16 hours. Filters were washed in 2X SSC and 1% SDS at 60°C. The NF-IL6 probe was a 100-bp Pst IlEcoRI fragment containing a leucine zipper motif in clone IS3.* The CiEBP antisense (5'-TGGTCTGGCCGCAGTGTGCGATCTG-GAACTGCAAGTG-3') oligonucleotide was used for the CIEBP probe.' Northern blot analysis. . The synthesized cDNA was subjected to the PCR with Tth-I DNA polymerase (Toyobo Co, Osaka, Japan) and NF-IL6 primers described as follows: NF-IL6 primers': 5'-GCGCGAGCGCAA-CAACATC-3' (nucleotides 1,127-1,146); 5'-TGCITGAACAAGT-TCCGCAG-3' (nucleotides 1,295-1,275). The reaction mixture was separated in 3% agarose gel and Southern blot analysis was performed with the NF-IL6 probe.
Nuclear extract was prepared from 5 x IO'U937 cells with the method of hypotonic Dounce homogenization followed by 0.4 mol/L NaCI extraction. The nuclear extract was diluted fivefold with 10 mmol/L Tris-HCI (pH KO), 1 mmol/L EDTA and mixed with 20 pg of poly(d1-dC)(dl-dC) (Pharmacia LKB Biotechnology) and 50 pmol of biotinilated oligo-4xNFIL6 DNA containing four NF-IL6 binding sites. The oligo-DNA was as follows: 4xNFIL6: GATCTAGAT-CAATCTAGATTGCACAATCTATC. The DNA-protein complexes were isolated by streptavidin-dynabeads (Dynal. Oslo, Noway) and subjected to SDS-polyacrylamide gel electrophoresis (SDS-PAGE) under reduced condition, followed by electrotransfer to polyvinylidene difluoride (PVDF) membrane, Trans-Blot (Bio-Rad, Richmond, CA). Anti-NF-IL6 peptide antiserum' was used as the first antibody. Alkali phosphatase method was used for the detection.
A 70-bp fragment (-180/-11 1 bp region) containing the NF-IL6 binding site in the human IL-6 gene was end-labeled with "P deoxynucleotides and Klenow fragment. The NF-IL6-p-galactosidase fusion protein' was incubated at 4°C for 30 minutes with the "P-labeled fragments in 30 pL of binding buffer consistingof 10 mmol/L HEPES (pH 7.9), 50 mmol/L NaCI. 5 mmol/LTris-HCI (pH 7.0). 1 mmol/L dithiothreitol, 15 mmol/L EDTA, 10% glycerol, and 2 to 4 kg of the carrier polymer Oligo-DNA affinity pttrijicatiorr and Westem hlot analvsk.
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Gel retardation assay. poly(d1-dC)(dI-dC) with or without a 100 molar exes of cold competitors. The DNA-protein complexes were then separated in 5% polyacrylamide gel (acrylamide to bisacrylamide ratio of 30: I ) containing 7 mmol/L Tris-HCI (pH 7.5), 3.3 mmol/L sodium acetate, 3.8 mmol/L 2-mercaptoethanol. and 1 mmol/L EDTA. Cold competitors used for competition gel retardation assay was as TCAACAGAGAAATTT, TNFa": CCCCAACTTTCCAAATC-C C C granulocyte colony-stimulating factor (G-CSF)": CGATT-TCACAAAAACTTTCGCAAACAGCTTTTTC: Lysozyme'": ATATTGCAACAGACTA: somatostatin (c-AMP response element): CGCCTCCTTGGCTGACGTCAGAGA.
The probe was "P-labeled at one 5' end and partially methylated with dimethyl sulfate (DMS) as described by Maxam and Gilbert.-" The methylated DNA probe was incubated with the p-galactosidase-NF-lL6 fusion protein.
After electrophoretic separation and brief autoradiograph, the protein-bound and free oligonucleotide probes were cut out and recovered from the gel. After cleavage with piperidine. approximately equal amounts of radioactivity for each sample were electrophoresed on 10% acrylamide 6 mol/Lurea gel and autoradiographed.
follows: IL-1 TTTAACTTGATTGTGAAATCAGGTAT-
Methylation interference a s s a~
RESULTS
Marked increase of NF-IL6 mRNA accompanies mocrophage differentiation. Mouse myeloid leukemia M1 cells are myeloblastic in morphology and can be induced to differentiate into macrophages after exposure to IL-6. M1 cells expressed a very low level of NF-IL6 mRNA before stimulation. Whcn the change of NF-IL6 mRNA lcvcl was examined along with the macrophage differentiation, a small peak of NF-IL6 mRNA induction occurred at 3 hours after IL-6 treatment; subsequently, NF-IL6 mRNA lcvcl decreased and again increased markedly after 2 days ( Fig  1A) . The second increase of NF-IL6 mRNA coincided with 
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For personal use only. on October 3, 2017. by guest www.bloodjournal.org From the morphologic change characteristic to a macrophage, although the significance of the first peak of NF-IL6 mRNA induction is not known at present. On the other hand, the expression of IL-6 mRNA in M1 cells was detectable by 12 hours, reached the maximum level at 2 days, and decreased to a basal level despite the high level expression of NF-IL6 mRNA. C/EBP mRNA was constitutively expressed before stimulation but did not increase, and rather decreased during the macrophage differentiation. The effect of LIF, another potent inducer of MI cell differentiation, was also studied. LIF seemed to be more potent in the capacity of the differentiation induction. By 24 hours, M1 cells exhibited the morphologic change and adhered to the plastic flask. As shown in Fig lB, LIF upregulated NF-IL6 mRNA and IL-6 mRNA, but downregulated C/EBP mRNA at 24 hours after stimulation.
In human monocytic leukemia cells, U937, that differentiate into cells with macrophage characteristics after exposure to LPS plus PMA, similar kinetics of the NF-IL6, IL-6, and C/EBP gene expression were observed (Fig 2A) . 
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NF-IL6 mRNA level increased markedly after 1 day, whereas C/EBP mRNA remained constant. IL-6 mRNA was transiently induced with maximum 1 day after stimulation.
Furthermore, it was examined whether the expression of NF-IL6 mRNA correlated with the expression of the functional NF-IL6 protein during the differentiation of U937 cells (Fig 2B) . The nuclear extracts from untreated and LPS/PMA-treated U937 cells were incubated with a synthetic biotinylated oligonucleotide containing four NF-IL6 binding motifs and subsequently the DNA-protein complexes were recovered by streptavidin-magnetic beads. The NF-IL6 protein was detected by Western blot analysis. The amount of functional NF-IL6 protein was not barely detectable before stimulation but increased markedly after stimulation, and reached maximum at 24 hours with a significant decrease during another 24 hours, although the mRNA did not decrease between them. This discrepancy suggests existence of a posttranscriptional regulation for the NF-IL6 expression. To determine whether the induction of NF-IL6 mRNA was specific for macrophage differentiation, the change of NF-IL6 mRNA was examined in human HL-60 promyclocytic cells, which undergo granulocyte or macrophage differentiation depending on the inducers. HL-60 cells were treated with PMA for differentiation towards macrophages and with DMSO towards granulocyte, respectively. As shown in Fig 3, NF-IL6 mRNA was specifically upregulated during macrophage differentiation but not during granulocyte differentiation. Taken together, these results showed that NF-IL6 mRNA was specifically induced during macrophage differentiation.
The expression of NF-IL6 mRNA in normal human peripheral monocytes was examined. Total cellular RNA was extracted from human peripheral monocytes with and without LPS stimulation and was reverse-transcribed. The synthesized cDNA was amplified by PCR method and the product was detected by Southern blot analysis using the NF-IL6 cDNA probe. As shown in Fig 4, NF-IL6 mRNA was expressed at a low level in human pcripheral monocytes and significantly increased with treatment of LPS (10 pg/mL) for 16 hours in vitro. This result shows that normal macrophage activation accompanies NF-IL6 mRNA induct ion.
Binding of recombinant NF-IL6 IO the regulatory regions of the genes activated in macrophages. Upon stimulation with a variety of agents, including LPS, macrophages produce inflammatory cytokines such as IL-1, TNF, and IL-6. NF-IL6 binding motifs were identified in the promoter regions of these genes (Fig 5A) . By a competition gelretardation assay, the binding of recombinant NF-IL6 to these sequcnces was ascertained (Fig 5B) . Recently, Nishizawa and Nagata'" found three regulatory elements (GPEl, GPEZ, and GPE3) in the promoter of the G-CSF gene by analyzing a set of linker-scanning mutants and internaldeletion mutants and showed that G-CSF proximal regulatory element 1 (GPEl) played an important role in the LPS-induced expression of the G-CSF gene in macrophages. In the sequence of GPEl (Fig 5A) , an NF-IL6 binding motif was identified and the specific binding of recombinant NF-IL6 to the sequence was observed (Fig 5B and C) . The lysozyme gcnc was also shown to be activated during macrophage differentiation. Recombinant NF-IL6 was IL-6 gene was incubated with the NF-L6+-galactosidase fusion protein alone or in the presence of the indicated competitors described in Materials and Methods and subjected t o a gel-retardation assay. CRE represents a c-AMP response element in the somatostatin gene and was used as a negative control for the competition assay. An arrow indicates a specific band between the NF-ILG-+galactosidase fusion protein and the probe. The faster migrating bands are nonspecific. (C) Methylation interference assays. The NF-IL6-@galactosidase fusion protein was incubated in a binding reaction with end-labeled, partially methylated fragments containing the NF-IL6 binding motifs of the mouse G-CSF and the chicken lysozyme genes, respectively. Specific complexes and free probes were separated on preparative band-shift 1 gels. The DNAs were eluted from the gel, chemically cleaved at methylated guanine residues, and fractionated on sequencing gels. Guanine residues that ( 0 ) markedly and ( : ) partially interfere with binding when methylated are indicated. C, coding strand; NC, noncoding strand; F, DNA from the free probe; B, DNA from the specific complex.
For personal use only. on October 3, 2017. by guest www.bloodjournal.org From shown to bind to the sequence (Fig 5A) , which was functionally important for the expression of the lysozyme gene" (Fig 5B and C) . These results indicate that NF-IL6 may play an important role in the regulation of the several genes associated with macrophage activation and/or differentiation.
DISCUSSION
In the present study, we showed that NF-IL6 mRNA levels increased drastically during macrophage differentiation, suggesting that NF-IL6 may play an important role in the expression of the genes activated during macrophage differentiation. In fact, the NF-IM binding consensus sequences were identified in the regulatory regions of the genes expressed in macrophage, including the IL-1, TNF, G-CSF, and lysozyme genes.
An intriguing finding in this study is the shut off of IL-6 mRNA despite the high level of NF-IM mRNA expression. This finding is consistent with the decline of IL-6 expression along with terminal maturation of macrophages, previously reported by Bauer et al.*' Although the mechanism for this decline of IL-6 mRNA is unknown, decrease of the functional NF-IL6 protein between 24 and 48 hours after stimulation is suspected to be responsible in part for this decline. At the same time, IL-6 mRNA may be destabilized in mature macrophages because of the presence of an AUUUA sequence in the 3' untranslated region, which has been associated with short mRNA half-lives.** Further study will be required to clarify this point.
Another interesting finding is the expression of both NF-IL6 and C/EBP mRNAs in hematopoietic lineage cells. We previously provided evidence that a reciprocal expression between NF-IL6 and C/EBP may modulate the liverspecific genes.23 C/EBP is involved in the expression of a variety of the liver-specific genes such as the albumin and the transthyretin genes in a normal condition, while NF-IL6 is expressed at a low level under this condition. However, once acute inflammation takes place, NF-IM is rapidly and drastically induced and involved in the induction of positive acute-phase proteins including haptoglobin, hemopexin, and C-reactive protein. In contrast, CiEBP is downregulated during the acute-phase reaction, resulting in a decreased transcription of negative acute-phase proteins such as albumin and transthyretin. In this respect, it is noteworthy that many of the hepatic acute-phase genes are expressed, although, to a lesser extent, in extrahepatic cell types including macrophages, strongly suggesting that NF-IL6 induction is responsible for acute-phase protein expression in the macrophage as well as in the liver.
Furthermore, Christy et all2 showed that C/EBP increased markedly during differentiation of 3T3-Ll preadipocytes to adipocytes and transactivate the promoters of the adipocyte-specific genes, 422(aP2) and SCD1, whereas NF-IL6 expression remained constant. These findings indicate that differential expression of NF-IL6 and C/EBP may modulate gene expression in diverse cell types.
Recently, heterodimer formation between the members of C/EBP family was shown in ~i t r o .~,~,~ Two or more of the members of C/EBP family are coexpressed in some cell types. In these cells they may exist in the form of heterodimers as well as homodimers, and the heterodimers may give rise to distinct transcriptional activities from the homodimers. Differential use of the homodimers and heterodimers among the C/EBP family members may modulate the expression of the different genes involved in the process of signal transduction and cell differentiation.
More detailed experiments about in vivo association between C/EBP family members will be needed.
